Inhibition of sodium-potassium activated brain adenosine triphosphatase (Na plus-K plus-ATPase) by adrenergic blocking alkylating agents.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000201:enzymology*; D002417:Cattle; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011188:Potassium; D012964:Sodium; D013565:Sympatholytics / Q000494:pharmacology*
D000477:Alkylating Agents; D013565:Sympatholytics; D010643:Phenoxybenzamine; D003983:Dibenzylchlorethamine; D000255:Adenosine Triphosphate; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium; D009638:Norepinephrine